Gmp Synthesis Chemistry Services Organisation, Onyx Scientific, Announce Increased Demand for Early-phase Investigational New Drug (IND) Development
Onyx Scientific excel in streamlining GMP synthesis processes. Their compliance standards minimise impurities, reduce costs and significantly improve timelines for phase I and II clinical studies.
View as PDF
March 23, 2011 (FPRC) -- Leading chemistry services organisation, Onyx Scientific Ltd, is pleased to announce an increased demand for its early-phase, GMP synthesis, Investigational New Drug (IND) services for the development of Active Pharmaceutical Ingredients (APIs).
'At Onyx we plan for success by focussing on detail' explains CEO Tony Flinn. 'Our service driven systems deliver comprehensive chemical route development, efficient raw materials sourcing, thorough analysis and world-class solid-state characterization. We are recognised as the leading GMP synthesis provider and are increasingly viewed as THE company to support the development of value for money INDs'.
Dr Daryl Rees, Chief Executive, Salupont Consulting comments, 'Having worked with Onyx Scientific for many years, I can say they are one of the finest suppliers in the marketplace. They have delivered a range of different services both on time and on budget, without hidden costs. Their GMP offering has been of particular use to us and we continually find that Onyx delivers excellent value for money'.
An equally valued client adds, 'I don't think thereís another team Iíve worked with who respond so quickly and flexibly to the regulators, and to my many questions. All data generated is of the highest quality. My many calls are met with good humour, practicality, pragmatism and a lot of patience. It's genuinely rare to work with a partner who demonstrates such a high degree of commitment. Reagents were ordered ahead of me asking, Onyx worked late, missed holiday leave and ran experiments over the weekend. The service they provide is above and beyond anything I'd have expected and it has made my job here so much easier'.
Good manufacturing practice (GMP) compliance is an international requirement for the manufacture of medicinal products for human and veterinary use. Compliance ensures medicinal products are produced safely and correctly. GMP Synthesis is the term commonly associated with manufacturing for Clinical Phases 1 to 3.
In addition to GMP synthesis and scale up, Onyx Scientificís breath of services include solid-form polymorph screening, salt selection, custom synthesis, process development and lead optimization.
Send an email to Sue Jones of Onyx Scientific Ltd
+44 (0) 191 516 6516
Recent Press Releases By The Same User
Custom Synthesis Chemistry Services CRO, Onyx Scientific, Hails the Success of Its Solid-state Polymorph Screening Services (Tue 28th Dec 10)
Solid-state Chemistry Services CRO, Onyx Scientific Reports Increased Demand for Polymorph Screening, Salt Selection and Crystallization Studies (Thu 11th Nov 10)
Gmp Synthesis Chemistry Services CRO, Onyx Scientific, Reports Increased Small Scale Production for Phase I and II Clinical Studies (Fri 3rd Sep 10)
Polymorph Screening Chemistry Services CRO, Onyx Scientific, Announces the Continued Strong Growth of Its Solid-state Services (Tue 6th Jul 10)
Onyx Scientific Grows API GMP Synthesis Contract Chemistry Services (Fri 9th Apr 10)